» Articles » PMID: 39284912

Acidity Suppresses CD8 + T-cell Function by Perturbing IL-2, MTORC1, and C-Myc Signaling

Overview
Journal EMBO J
Date 2024 Sep 16
PMID 39284912
Authors
Affiliations
Soon will be listed here.
Abstract

CD8 + T cells have critical roles in tumor control, but a range of factors in their microenvironment such as low pH can suppress their function. Here, we demonstrate that acidity restricts T-cell expansion mainly through impairing IL-2 responsiveness, lowers cytokine secretion upon re-activation, and reduces the cytolytic capacity of CD8 + T cells expressing low-affinity TCR. We further find decreased mTORC1 signaling activity and c-Myc levels at low pH. Mechanistically, nuclear/cytoplasmic acidification is linked to mTORC1 suppression in a Rheb-, Akt/TSC2/PRAS40-, GATOR1- and Lkb1/AMPK-independent manner, while c-Myc levels drop due to both decreased transcription and higher levels of proteasome-mediated degradation. In addition, lower intracellular levels of glutamine, glutamate, and aspartate, as well as elevated proline levels are observed with no apparent impact on mTORC1 signaling or c-Myc levels. Overall, we suggest that, due to the broad impact of acidity on CD8 + T cells, multiple interventions will be required to restore T-cell function unless intracellular pH is effectively controlled.

Citing Articles

Preclinical model for evaluating human TCRs against chimeric syngeneic tumors.

Semilietof A, Stefanidis E, Gray-Gaillard E, Pujol J, DEsposito A, Reichenbach P J Immunother Cancer. 2025; 12(12.

PMID: 39794936 PMC: 11667476. DOI: 10.1136/jitc-2024-009504.


Acidic pH can attenuate immune killing through inactivation of perforin.

Hodel A, Rudd-Schmidt J, Noori T, Lupton C, Cheuk V, Trapani J EMBO Rep. 2025; 26(4):929-947.

PMID: 39789387 PMC: 11850619. DOI: 10.1038/s44319-024-00365-6.

References
1.
Marchingo J, Sinclair L, Howden A, Cantrell D . Quantitative analysis of how Myc controls T cell proteomes and metabolic pathways during T cell activation. Elife. 2020; 9. PMC: 7056270. DOI: 10.7554/eLife.53725. View

2.
Vuillefroy de Silly R, Dietrich P, Walker P . Hypoxia and antitumor CD8 T cells: An incompatible alliance?. Oncoimmunology. 2017; 5(12):e1232236. PMC: 5214994. DOI: 10.1080/2162402X.2016.1232236. View

3.
Rogala K, Gu X, Kedir J, Abu-Remaileh M, Bianchi L, Bottino A . Structural basis for the docking of mTORC1 on the lysosomal surface. Science. 2019; 366(6464):468-475. PMC: 7176403. DOI: 10.1126/science.aay0166. View

4.
Wang R, Dillon C, Shi L, Milasta S, Carter R, Finkelstein D . The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity. 2011; 35(6):871-82. PMC: 3248798. DOI: 10.1016/j.immuni.2011.09.021. View

5.
Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, Edinger M . Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood. 2007; 109(9):3812-9. DOI: 10.1182/blood-2006-07-035972. View